Protection by BTCP of cultured dopaminergic neurons exposed to neurotoxins.
This study presents 'in vitro' evidence for a protection of cultured dopaminergic neurons against the toxicity of 6-hydroxydopamine (6-OHDA) and 1-methyl-4-phenylpyridinium (MPP+) by pretreatment with BTCP, a selective and potent dopamine (DA) uptake blocker. Moreover, we show that, at low concentration (10 nM), treatment with MPP+, which is more selective than 6-OHDA for dopaminergic neurons, is followed by some regeneration of these neurons.